EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSONIG00000015441
Gene Symbol: F2R
1 Cross references
247 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSONIG00000042992
Gene Symbol: F2R
3 Cross references
248 Possible Orthologues:

Coagulation Factor Iiia

Ensembl ID : ENSONIG00000009666
Gene Symbol: F3A
1 Cross references
199 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSONIG00000008995
Gene Symbol: LOC100704738
3 Cross references
77 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSONIG00000027293
Gene Symbol: F7L
1 Cross references
77 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSONIG00000031915
Gene Symbol: F10
1 Cross references
232 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSONIG00000008990
Gene Symbol: F10
1 Cross references
234 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSONIG00000037673
Gene Symbol: CCDC6
3 Cross references
207 Possible Orthologues:

Collagenase 3

Ensembl ID : ENSONIG00000015881
Gene Symbol: LOC100711125
2 Cross references
278 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSONIG00000013065
Gene Symbol: CSF1R
4 Cross references
63 Possible Orthologues:

Complement C5

Ensembl ID : ENSONIG00000000645
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSONIG00000038106
Gene Symbol: CRHR1
4 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).